I truly love this site and JDA’s constant commitment to speaking her mind, delivering lively commentary on economic events, and throwing in the perfect picture to go with it. So Happy 2nd Birthday, JDA!! – Ilene
Couldn’t have done it without you, stalker, commenter, subscriber, reader, casual checker outer, supporter, donor, asshat and nemesis. I’d especially like to thank Ben Bernanke for making this moment possible, were it not for his constant shenanigans, I would not have had a single thing to write about these past two years and my little world would be that much emptier.
Thanks to TLP for carrying the load when Google is pissing me off and/or hating and being my constant source of entertainment when everything else sucks raw donkey balls.
Thanks to my wonderfully strange readers who delight and fascinate me all while feeding my constantly hungry ego.
And thanks most of all to J.P. Morgan and the fine Rothschild family; were it not for your hard diabolical work, I really wouldn’t have anything at all to say as this world just wouldn’t need me.
While I’m thrilled to say JDA is celebrating two years on this trip, I have to say I certainly didn’t think I’d still have so much to write about on the financial doomsday front two years later. Oh well. See you kids in a decade, I’ll still be here bitching about Fed asshats and the pending commercial real estate collapse, I’m sure.
It’s been a long exciting week filled with Greece action, Obamacare, and failed Treasury auctions. Since JDA’s resident paperboy doesn’t believe the Fed is an evil institution and tends to read too much HuffPo and not enough Ron Paul, I’m grabbing the paper, rolling it up and whacking him (hard) with the following:
It’s Official – America Now Enforces Capital Controls Gee, think we should start reading the bill? (Zero Hedge)
Goldman Sachs’ controversial ‘mommy-track’ In fairness to TLP, he didread this one. You should too. (The Week)
Does Unemployment Insurance Cause Unemployment? It’s a legitimate question. Does the FDIC encourage moral hazard? Mmm hmm. (Wall St Cheat Sheet)
On Deficits And Debt-Financed Government Market Ticker is always good for a nice reality check. Especially one that comes out to $760 billion in interest expense alone – and yes, that’s American debt. (Market Ticker)
The “shop till you drop” economy "Who would want to invest in the United States when there are fiscally solvent, rapidly growing emerging economies to invest in?" Who indeed. (The Animal Spirits Page)
Throwing Gas On The Fire Wait a second, are the regulators the problem? (Bank Lawyer’s Blog)
Repo 105: Was Lehman’s Accounting Only Ticking Boxes? Or Is It A Ticking Box? I smell smoke, Jim Peterson smells something awry with financial reporting (as in journalism, not statements) and rules-based accounting. JDA humbly concurs. (Re:Balance)
Is InterOil Built on a Foundation of Fraud? InterOil better look out, you don’t want Sam Antar on your ass (I’m not scared, he’s afraid of me and I’m training him for his next bout) (White Collar Fraud)
TGIF – Greece Fixed AGAIN! Phil seems to think the EU is bipolar. Has the EU asked its doctor about Abilify? (Phil’s Stock World)
The Latest To Get Ripped Off By The Banksters? The States I’m shocked. Completely and totally shocked.(LOLFed)
If there’s one thing we have learned about Barack Obama, it’s that he is a master of deception and absolutely loves to lie to the public. He seems to enjoy conning the plebs to such a degree, I think he actually receives blasts of dopamine every time he does it. The bigger the lie, the better the rush.
The latest example relates to his issuance of executive orders, or lack thereof, something that Obama Inc...
Break-even rates are the difference between treasuries and the same-duration Treasury Inflation-Protected Securities (TIPS). The break-even rate turned negative yesterday for the first time since 2009.
In theory, break-even rates reflect investors’ expectations for inflation over the life of the securities.
When break-even rates are negative, it's an indication investors expect price deflation for the duration, in this case for two years.
From Bloomberg ... The drop in the break-even rate followed a Labor Depart...
Those who took advantage of markets at Fib levels were rewarded. However, this looked more a 'dead cat' style bounce than a genuine bottom forming low. This can of course change, and one thing I will want to see is narrow action near today's high. Volume was a little light, but with Christmas fast approaching I would expect this trend to continue.
The S&P inched above 2,009, but I would like to see any subsequent weakness hold the 38.2% Fib level at 1,989.
The Nasdaq offered itself more as a support bounce, with a picture perfect play off its 38.2% Fib level. Unlike the S&P, volume did climb in confirmed accumulation. The next upside c...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
Stocks have needed a reason to take a breather and pull back in this long-standing ultra-bullish climate, with strong economic data and seasonality providing impressive tailwinds -- and plummeting oil prices certainly have given it to them. But this minor pullback was fully expected and indeed desirable for market health. The future remains bright for the U.S. economy and corporate profits despite the collapse in oil, and now the overbought technical condition has been relieved. While most sectors are gathering fundamental support and our sector rotation model remains bullish, the Energy sector looks fundamentally weak and continues to ran...
Stocks got off to a rocky start on the first trading day in December, with the S&P 500 Index slipping just below 2050 on Monday. Based on one large bullish SPX options trade executed on Wednesday, however, such price action is not likely to break the trend of strong gains observed in the benchmark index since mid-October. It looks like one options market participant purchased 25,000 of the 31Dec’14 2105/2115 call spreads at a net premium of $2.70 each. The trade cost $6.75mm to put on, and represents the maximum potential loss on the position should the 2105 calls expire worthless at the end of December. The call spread could reap profits of as much as $7.30 per spread, or $18.25mm, in the event that the SPX ends the year above 2115. The index would need to rally 2.0% over the current level...
I officially bought 250 shares of EZCH at $18.76 and sold 300 shares of IGT at $17.09 in Market Shadows' Virtual Portfolio yesterday (Fri. 11-21).
Click here for Thursday's post where I was thinking about buying EZCH. After further reading, I decided to add it to the virtual portfolio and to sell IGT and several other stocks, which we'll be saying goodbye to next week.
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW)
nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Site owned and operated by PSW Investments, LLC. Contact us at: 403 Central Avenue, Hawthorne, NJ 07506. Phone: (201) 743-8009. Email: email@example.com.